EA202091832A1 - Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины - Google Patents
Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платиныInfo
- Publication number
- EA202091832A1 EA202091832A1 EA202091832A EA202091832A EA202091832A1 EA 202091832 A1 EA202091832 A1 EA 202091832A1 EA 202091832 A EA202091832 A EA 202091832A EA 202091832 A EA202091832 A EA 202091832A EA 202091832 A1 EA202091832 A1 EA 202091832A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- platinum
- pentaase
- macrocyclic
- agent based
- antitumor agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ лечения злокачественного новообразования у млекопитающего, страдающего злокачественным новообразованием, по существу включающий введение субъекту терапевтически эффективного количества противоопухолевого агента на основе платины, и введение субъекту терапевтически эффективного количества макроциклического кольцевого комплекса пентаазы, соответствующего приведенной ниже формуле (I), до, одновременно или после введения противоопухолевого агента на основе платины, за счет чего усиливается реакция злокачественного новообразования на противоопухолевый агент на основе платины.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862624250P | 2018-01-31 | 2018-01-31 | |
PCT/US2019/016071 WO2019152661A1 (en) | 2018-01-31 | 2019-01-31 | Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091832A1 true EA202091832A1 (ru) | 2021-01-11 |
Family
ID=67479466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091832A EA202091832A1 (ru) | 2018-01-31 | 2019-01-31 | Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины |
Country Status (14)
Country | Link |
---|---|
US (1) | US20210338686A1 (ru) |
EP (1) | EP3746085A4 (ru) |
JP (2) | JP2021512110A (ru) |
KR (1) | KR20200118823A (ru) |
CN (1) | CN111902147A (ru) |
AU (1) | AU2019215032A1 (ru) |
BR (1) | BR112020015520A2 (ru) |
CA (1) | CA3090129A1 (ru) |
EA (1) | EA202091832A1 (ru) |
IL (1) | IL276407A (ru) |
MX (1) | MX2020008028A (ru) |
PH (1) | PH12020551176A1 (ru) |
SG (1) | SG11202007317XA (ru) |
WO (1) | WO2019152661A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE044234T2 (hu) | 2006-10-12 | 2019-10-28 | Galera Labs Llc | Eljárások szájnyálkahártya-gyulladás kezelésére |
WO2013048965A1 (en) | 2011-09-26 | 2013-04-04 | Galera Therapeutics, Llc | Methods for treatment of diseases |
JP2019131508A (ja) * | 2018-01-31 | 2019-08-08 | ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーGalera Labs, Llc | ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法 |
WO2024026273A1 (en) * | 2022-07-25 | 2024-02-01 | Galera Labs, Llc | Therapy for reduced ototoxicity from chemotherapeutic agent with pentaaza macrocyclic ring complex |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW197439B (ru) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
CA2072934C (en) | 1991-07-19 | 2007-08-28 | Karl William Aston | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
US5440056A (en) | 1992-04-17 | 1995-08-08 | Abbott Laboratories | 9-deoxotaxane compounds |
JPH08500973A (ja) | 1992-05-21 | 1996-02-06 | ザ ペン ステイト リサーチ ファウンデーション | タキソール、関連タキサン及び他の新規な抗癌/抗ウイルス性化合物原料としてのイチイ培養組織 |
US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
US6204259B1 (en) | 1993-01-14 | 2001-03-20 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
US5824701A (en) | 1993-10-20 | 1998-10-20 | Enzon, Inc. | Taxane-based prodrugs |
US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
US6245758B1 (en) | 1994-05-13 | 2001-06-12 | Michael K. Stern | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
US6525041B1 (en) | 1995-06-06 | 2003-02-25 | Pharmacia Corporation | Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
CA2229777A1 (en) | 1995-08-17 | 1997-02-27 | Monsanto Company | Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands |
WO1998008833A1 (en) | 1996-08-26 | 1998-03-05 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
WO1998013059A1 (en) | 1996-09-27 | 1998-04-02 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
WO1998022451A1 (fr) | 1996-11-19 | 1998-05-28 | Daiichi Pharmaceutical Co., Ltd. | Derives taxol |
US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
US6214817B1 (en) | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
HUP0002521A3 (en) | 1997-06-20 | 2002-04-29 | Baker Norton Pharma | Onium salts of paclitaxel, process for producing them and medicaments comprising the same |
US6180620B1 (en) | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
CA2561266A1 (en) * | 2004-03-29 | 2005-10-20 | Inotek Pharmaceuticals Corporation | Pyridyl-substituted porphyrin compounds and methods of use thereof |
US20070148154A1 (en) * | 2004-12-17 | 2007-06-28 | Universite Rene Descartes (Paris V) | Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs |
WO2006078713A2 (en) * | 2005-01-19 | 2006-07-27 | Metaphore Pharmaceuticals, Inc. | Methotrexate combinations for treating inflammatory diseases |
EP2020998A4 (en) * | 2006-05-23 | 2010-07-21 | Univ Utah Res Found | COMPOSITIONS AND METHODS OF INHIBITING THE ENDOTHELIAL STAIN OXIDE SYNTHASE ACTIVITY |
HUE044234T2 (hu) * | 2006-10-12 | 2019-10-28 | Galera Labs Llc | Eljárások szájnyálkahártya-gyulladás kezelésére |
EP2859916B1 (en) * | 2008-05-22 | 2017-11-29 | Galera Labs, LLC | Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy |
WO2013048965A1 (en) * | 2011-09-26 | 2013-04-04 | Galera Therapeutics, Llc | Methods for treatment of diseases |
SG11201809606YA (en) * | 2016-05-03 | 2018-11-29 | Galera Labs Llc | Combination therapy for cancer treatment |
-
2019
- 2019-01-31 CA CA3090129A patent/CA3090129A1/en active Pending
- 2019-01-31 EA EA202091832A patent/EA202091832A1/ru unknown
- 2019-01-31 AU AU2019215032A patent/AU2019215032A1/en active Pending
- 2019-01-31 CN CN201980019662.4A patent/CN111902147A/zh active Pending
- 2019-01-31 MX MX2020008028A patent/MX2020008028A/es unknown
- 2019-01-31 US US16/965,476 patent/US20210338686A1/en active Pending
- 2019-01-31 EP EP19747505.6A patent/EP3746085A4/en active Pending
- 2019-01-31 SG SG11202007317XA patent/SG11202007317XA/en unknown
- 2019-01-31 JP JP2020541809A patent/JP2021512110A/ja active Pending
- 2019-01-31 BR BR112020015520-9A patent/BR112020015520A2/pt not_active Application Discontinuation
- 2019-01-31 WO PCT/US2019/016071 patent/WO2019152661A1/en unknown
- 2019-01-31 KR KR1020207024560A patent/KR20200118823A/ko unknown
-
2020
- 2020-07-30 PH PH12020551176A patent/PH12020551176A1/en unknown
- 2020-07-30 IL IL276407A patent/IL276407A/en unknown
-
2024
- 2024-02-09 JP JP2024018847A patent/JP2024054295A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20200118823A (ko) | 2020-10-16 |
PH12020551176A1 (en) | 2021-06-07 |
EP3746085A1 (en) | 2020-12-09 |
MX2020008028A (es) | 2020-12-11 |
JP2024054295A (ja) | 2024-04-16 |
IL276407A (en) | 2020-09-30 |
JP2021512110A (ja) | 2021-05-13 |
EP3746085A4 (en) | 2022-03-09 |
US20210338686A1 (en) | 2021-11-04 |
WO2019152661A1 (en) | 2019-08-08 |
BR112020015520A2 (pt) | 2021-02-02 |
SG11202007317XA (en) | 2020-08-28 |
CA3090129A1 (en) | 2019-08-08 |
CN111902147A (zh) | 2020-11-06 |
AU2019215032A1 (en) | 2020-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202091832A1 (ru) | Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины | |
EA202091514A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ РАКА ТОЛСТОЙ КИШКИ С ИСПОЛЬЗОВАНИЕМ КОМБИНИРОВАННОЙ ТЕРАПИИ НАНОЧАСТИЦАМИ С ИНГИБИТОРОМ mTOR | |
EA201892510A3 (ru) | Комбинированная терапия для лечения рака | |
BR112016012506A2 (pt) | Combinações farmacêuticas, seus usos, e uso de um portador de dados | |
BR112019007844A2 (pt) | tratamento de câncer gástrico usando terapias de combinação compreendendo irinotecano lipossômico, oxaliplatina, 5-fluoroacila (e leucovorina) | |
EA201590585A1 (ru) | Продукт, включающий никотинсодержащее вещество и противоопухолевое средство | |
MA37829A1 (fr) | Combinaisons pharmaceutiques comprenant un inhibiteur de b-raf, un inhibiteur d'egfr et facultativement un inhibiteur de pi3k alpha | |
MX2019012464A (es) | Terapia combinada con un conjugado de anticuerpo y farmaco anti-axl. | |
MX2017015896A (es) | Agente anticancerigeno. | |
PH12018501903A1 (en) | Methods of treating depression using orexin-2 receptor antagonists | |
EA201891575A1 (ru) | Составы для лечения рака мочевого пузыря | |
PH12018502422A1 (en) | Nanoliposomal irinotecan for use in treating small cell lung cancer | |
RU2017134443A (ru) | Способ лечения с применением традипитанта | |
EA201990428A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
EA201891514A1 (ru) | Комбинированная терапия ингибитором бромодомена и экстратерминального белка | |
RU2018127640A (ru) | Комбинация ингибитора hdac и антитела против pd-l1 для лечения рака яичников | |
MX2019012259A (es) | Inmunoterapia combinada contra el cancer con complejo de anillo pentaazamacrociclico. | |
WO2018045348A3 (en) | ANTICANCER POLY THERAPY WITH PENTAAZA MACROCYCLIC CYCLE COMPLEX AND ASCORBATE COMPOUND | |
EA201992658A1 (ru) | Методы лечения рекуррентной глиобластомы (rgbm) | |
PH12018500450A1 (en) | Immunity enhancing agent for cancer by allergin-1 antagonist | |
EA201400495A1 (ru) | Селективные ингибиторы, нарушающие взаимодействие рецептора фактора роста фибробластов и frs2, для профилактики и лечения рака и других заболеваний | |
TR201908138T4 (tr) | Bir anti-her2 antikoru ilaç konjügatı ve bir bcl-2 inhibitörü ile kombinasyon terapisi. | |
EA201892592A1 (ru) | Лечение мелкоклеточного рака легких с помощью липосомального иринотекана | |
MX2018015240A (es) | Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica. | |
BR112018070526A2 (pt) | tratamento do carcinoma de células renais com lenvatinibe e everolimo |